AMB-BISACODYL

ambicare pharmaceuticals inc.🇨🇦 Health Canada

Approval Id: ae4cc9bb9fc07248
Drug Approval Canada Name: AMB-BISACODYL
Product Name: AMB-BISACODYL
Status: Marketed
Status Date: 2024-06-03
Original Market Date: 2024-06-03
Din: 02520478
Drug Class: Human
Dosage Form: Suppository
Route Of Administration: Rectal
Schedule: OTC
Ahfs: 56:12.00
Atc Original: A06AB02 BISACODYL
Atc Name: a 06 ab 02
Aig Number: 0101506002
Company Name: ambicare pharmaceuticals inc.
Company Address: 302, 1670 North Service Road East, Oakville, Ontario, Canada, L6H 7G3

BISACODYL

10 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ae4cc9bb9fc07248

Type

Standard